KNSA logo

Kiniksa Pharmaceuticals (KNSA) Depreciation and amortization

annual D&A:

$1.70M-$646.00K(-27.60%)
December 31, 2024

Summary

  • As of today (May 31, 2025), KNSA annual depreciation & amortization is $1.70 million, with the most recent change of -$646.00 thousand (-27.60%) on December 31, 2024.
  • During the last 3 years, KNSA annual D&A has fallen by -$660.00 thousand (-28.03%).
  • KNSA annual D&A is now -29.52% below its all-time high of $2.40 million, reached on December 31, 2020.

Performance

KNSA Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAincome statement metrics

quarterly D&A:

$345.00K-$55.00K(-13.75%)
March 31, 2025

Summary

  • As of today (May 31, 2025), KNSA quarterly depreciation & amortization is $345.00 thousand, with the most recent change of -$55.00 thousand (-13.75%) on March 31, 2025.
  • Over the past year, KNSA quarterly D&A has dropped by -$121.00 thousand (-25.97%).
  • KNSA quarterly D&A is now -51.88% below its all-time high of $717.00 thousand, reached on June 30, 2021.

Performance

KNSA quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAincome statement metrics

TTM D&A:

$1.57M-$121.00K(-7.14%)
March 31, 2025

Summary

  • As of today (May 31, 2025), KNSA TTM depreciation & amortization is $1.57 million, with the most recent change of -$121.00 thousand (-7.14%) on March 31, 2025.
  • Over the past year, KNSA TTM D&A has dropped by -$637.00 thousand (-28.81%).
  • KNSA TTM D&A is now -41.68% below its all-time high of $2.70 million, reached on March 31, 2022.

Performance

KNSA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAincome statement metrics

KNSA Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.6%-26.0%-28.8%
3 y3 years-28.0%-47.4%-41.7%
5 y5 years-18.0%-41.9%-28.2%

KNSA Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-29.4%at low-47.4%at low-41.7%at low
5 y5-year-29.5%at low-51.9%+10.6%-41.7%at low
alltimeall time-29.5%+7604.6%-51.9%+5650.0%-41.7%>+9999.0%

KNSA Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$345.00K(-13.8%)
$1.57M(-7.1%)
Dec 2024
$1.70M(-27.6%)
$400.00K(+0.3%)
$1.70M(-7.6%)
Sep 2024
-
$399.00K(-7.2%)
$1.83M(-10.0%)
Jun 2024
-
$430.00K(-7.7%)
$2.04M(-7.8%)
Mar 2024
-
$466.00K(-13.7%)
$2.21M(-5.6%)
Dec 2023
$2.34M(-2.5%)
$540.00K(-10.4%)
$2.34M(-2.6%)
Sep 2023
-
$603.00K(+0.2%)
$2.40M(+4.8%)
Jun 2023
-
$602.00K(+1.0%)
$2.29M(-2.1%)
Mar 2023
-
$596.00K(-1.0%)
$2.34M(-2.5%)
Dec 2022
$2.40M(+2.0%)
$602.00K(+22.1%)
$2.40M(-2.7%)
Sep 2022
-
$493.00K(-24.3%)
$2.47M(-6.3%)
Jun 2022
-
$651.00K(-0.8%)
$2.63M(-2.4%)
Mar 2022
-
$656.00K(-1.8%)
$2.70M(+14.6%)
Dec 2021
$2.35M(-2.1%)
$668.00K(+1.5%)
$2.35M(+4.5%)
Sep 2021
-
$658.00K(-8.2%)
$2.25M(+0.4%)
Jun 2021
-
$717.00K(+129.8%)
$2.25M(+5.7%)
Mar 2021
-
$312.00K(-45.0%)
$2.12M(-11.7%)
DateAnnualQuarterlyTTM
Dec 2020
$2.40M(+16.3%)
$567.00K(-12.6%)
$2.40M(+0.0%)
Sep 2020
-
$649.00K(+9.1%)
$2.40M(+5.5%)
Jun 2020
-
$595.00K(+0.2%)
$2.28M(+4.0%)
Mar 2020
-
$594.00K(+4.9%)
$2.19M(+5.9%)
Dec 2019
$2.07M(+623.1%)
$566.00K(+8.2%)
$2.07M(+17.8%)
Sep 2019
-
$523.00K(+3.0%)
$1.76M(+41.0%)
Jun 2019
-
$508.00K(+7.9%)
$1.25M(+66.2%)
Mar 2019
-
$471.00K(+85.4%)
$749.00K(+161.9%)
Dec 2018
$286.00K(+921.4%)
$254.00K(+2016.7%)
$286.00K(+615.0%)
Sep 2018
-
$12.00K(0.0%)
$40.00K(+11.1%)
Jun 2018
-
$12.00K(+50.0%)
$36.00K(+20.0%)
Mar 2018
-
$8000.00(0.0%)
$30.00K(+7.1%)
Dec 2017
$28.00K(+27.3%)
$8000.00(0.0%)
$28.00K(+40.0%)
Sep 2017
-
$8000.00(+33.3%)
$20.00K(+66.7%)
Jun 2017
-
$6000.00(0.0%)
$12.00K(+100.0%)
Mar 2017
-
$6000.00
$6000.00
Dec 2016
$22.00K
-
-

FAQ

  • What is Kiniksa Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual D&A year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly D&A year-on-year change?
  • What is Kiniksa Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals TTM D&A year-on-year change?

What is Kiniksa Pharmaceuticals annual depreciation & amortization?

The current annual D&A of KNSA is $1.70M

What is the all time high annual D&A for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual depreciation & amortization is $2.40M

What is Kiniksa Pharmaceuticals annual D&A year-on-year change?

Over the past year, KNSA annual depreciation & amortization has changed by -$646.00K (-27.60%)

What is Kiniksa Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of KNSA is $345.00K

What is the all time high quarterly D&A for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly depreciation & amortization is $717.00K

What is Kiniksa Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, KNSA quarterly depreciation & amortization has changed by -$121.00K (-25.97%)

What is Kiniksa Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of KNSA is $1.57M

What is the all time high TTM D&A for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high TTM depreciation & amortization is $2.70M

What is Kiniksa Pharmaceuticals TTM D&A year-on-year change?

Over the past year, KNSA TTM depreciation & amortization has changed by -$637.00K (-28.81%)
On this page